Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (ChiCTR2500115048) titled 'Construction and Evaluation of a Digital Intelligent Intervention Program for Young Breast Cancer Survivors and Their Family Caregivers from a Strengths-Based Perspective' on Dec. 22, 2025.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: Renji Hospital, Shanghai Jiao Tong University School of Medicine
Condition:
Breast Cancer
Intervention:
Intervention group:Access to a WeChat-based digital intervention program, including information modules, peer discussion forums, intelligent content recommendations, and regular online follow-up for young breast cancer survivors and their family ...